Patents by Inventor Daniel Buck
Daniel Buck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10918816Abstract: A compliance monitoring module for a breath-actuated inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being pneumatically coupled to a flow channel through which a user can inhale; a processor configured to: receive a signal originating from a dosing mechanism of the inhaler indicating that medication has been released; receive data from a sensing element of the sensor; and based on said signal from said dosing mechanism and said data from said sensing element, make a determination that inhalation of a breath containing medication through said flow channel complies with one or more predetermined requirements for successful dosing; and a transmitter configured to, responsive to said determination, issue a dosing report.Type: GrantFiled: October 1, 2018Date of Patent: February 16, 2021Assignee: Norton (Waterford) LimitedInventors: Mark Steven Morrison, Douglas E. Weitzel, Enrique Calderon Oliveras, Daniel Buck
-
Patent number: 10905356Abstract: A compliance monitoring module for an inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being configured to be pneumatically coupled to a flow channel of said inhaler through which a user can inhale; a processor configured to: receive data from a sensing element of the pressure sensor; receive data from a mode sensor configured to detect when the inhaler changes from an inactive mode to an active mode; and based on said data from said pressure sensor sensing element and said data from said mode sensor, compile a compliance report; and a transmitter configured to issue said compliance report.Type: GrantFiled: August 28, 2015Date of Patent: February 2, 2021Assignee: Norton (Waterford) LimitedInventors: Mark Steven Morrison, Douglas E. Weitzel, Enrique Calderon Oliveras, Daniel Buck
-
Publication number: 20210016026Abstract: An inhaler includes a main body having a canister housing, a medicament canister retained in a central outlet port of the canister housing, and a dose counter having an actuation member for operation by movement of the medicament canister. The canister housing has an inner wall, and a first inner wall canister support formation extending inwardly from a main surface of the inner wall. The canister housing has a longitudinal axis X which passes through the center of the central outlet port. The first inner wall canister support formation, the actuation member, and the central outlet port lie in a common plane coincident with the longitudinal axis X such that the first inner wall canister support formation protects against unwanted actuation of the dose counter by reducing rocking of the medicament canister relative to the main body of the inhaler.Type: ApplicationFiled: June 29, 2020Publication date: January 21, 2021Inventors: Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg
-
Publication number: 20210016027Abstract: A breath actuated metered dose inhaler may comprise a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may comprise a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.Type: ApplicationFiled: October 2, 2020Publication date: January 21, 2021Applicant: Norton (Waterford) LimitedInventors: Declan Walsh, Paul Prendergast, Daniel Buck, Trevor Kent, Niall Thompson
-
Publication number: 20200360630Abstract: A system may include an external device and an inhaler. The external device may include a processor, a communication circuit, and memory. The inhaler may include a mouthpiece, medicament, a mechanical dose counter, and an electronics module comprising a processor and a communication circuit. The electronics module may record a dosing event when the inhaler is actuated, such as when the mouthpiece cover is opened, and send a signal indicating the dosing event to the external device. The external device may receive a mechanical dose reading of the mechanical dose counter, determine an electronic dose reading based on the signal indicating the dosing event, determine that a discrepancy between the mechanical dose reading and the electronic dose reading exceeds a threshold, and notify the user of the discrepancy, for example, by providing a notification to the user by way of a mobile application residing on the external device.Type: ApplicationFiled: May 15, 2020Publication date: November 19, 2020Applicant: Norton (Waterford) LimitedInventors: Enrique Calderon Oliveras, Daniel Buck
-
Patent number: 10821088Abstract: The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.Type: GrantFiled: September 10, 2014Date of Patent: November 3, 2020Assignee: PROPELLA THERAPEUTICS, INC.Inventors: Daniel Bucks, Philip J. Birbara
-
Publication number: 20200323800Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.Type: ApplicationFiled: January 16, 2020Publication date: October 15, 2020Inventors: Philip J. BIRBARA, Daniel Bucks
-
Patent number: 10792447Abstract: A breath actuated metered dose inhaler may include a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may include a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the so pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.Type: GrantFiled: January 25, 2019Date of Patent: October 6, 2020Assignee: NORTON (WATERFORD) LIMITEDInventors: Declan Walsh, Paul Prendergast, Daniel Buck, Trevor Kent, Niall Thompson
-
Patent number: 10695512Abstract: An inhaler includes a main body having a canister housing, a medicament canister retained in a central outlet port of the canister housing, and a dose counter having an actuation member for operation by movement of the medicament canister. The canister housing has an inner wall, and a first inner wall canister support formation extending inwardly from a main surface of the inner wall. The canister housing has a longitudinal axis X which passes through the center of the central outlet port. The first inner wall canister support formation, the actuation member, and the central outlet port lie in a common plane coincident with the longitudinal axis X such that the first inner wall canister support formation protects against unwanted actuation of the dose counter by reducing rocking of the medicament canister relative to the main body of the inhaler.Type: GrantFiled: November 6, 2017Date of Patent: June 30, 2020Assignees: Ivax Pharmaceuticals Ireland, Norton (Waterford) Limited, Teva Pharmaceuticals IrelandInventors: Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg
-
CRYOPROTECTANT FOR USE WITH A TREATMENT DEVICE FOR IMPROVED COOLING OF SUBCUTANEOUS LIPID-RICH CELLS
Publication number: 20200155215Abstract: A cryoprotectant for use with a treatment device for improved removal of heat from subcutaneous lipid-rich cells of a subject having skin is provided. The cryoprotectant is a non-freezing liquid, gel, or paste for allowing pre-cooling of the treatment device below 0° C. while preventing the formation of ice thereon. The cryoprotectant may also prevent freezing of the treatment device to the skin or ice from forming from moisture seeping out from the skin. The cryoprotectant may further be hygroscopic, thermally conductive, and biocompatible.Type: ApplicationFiled: October 8, 2019Publication date: May 21, 2020Inventors: Mitchell E. Levinson, Donald Johnson, Jessica Preciado, Edward A. Ebbers, Daniel Bucks -
Publication number: 20200129711Abstract: The present disclosure describes an inhaler for the inhalation of powder medication. The inhaler has a body and at least one reservoir containing powder medication, the body having an air inlet and an outlet for the transmission to a patient of air entering the body through the air inlet and powder medication. The outlet has a total cross-sectional area for flow which is more than 80% of the total cross-sectional area of the air inlet.Type: ApplicationFiled: January 16, 2018Publication date: April 30, 2020Applicant: NORTON (WATERFORD) LIMITEDInventor: Daniel Buck
-
Patent number: 10583100Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.Type: GrantFiled: January 9, 2019Date of Patent: March 10, 2020Assignee: VIZURI HEALTH SCIENCES LLCInventors: Philip J. Birbara, Daniel Bucks
-
Patent number: 10569034Abstract: A compliance monitoring module for a breath-actuated inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being pneumatically coupled to a flow channel through which a user can inhale; a processor configured to: receive a signal originating from a dosing mechanism of the inhaler indicating that medication has been released; receive data from a sensing element of the sensor; and based on said signal from said dosing mechanism and said data from said sensing element, make a determination that inhalation of a breath containing medication through said flow channel complies with one or more predetermined requirements for successful dosing; and a transmitter configured to, responsive to said determination, issue a dosing report.Type: GrantFiled: August 18, 2017Date of Patent: February 25, 2020Assignee: Norton (Waterford) LimitedInventors: Mark Steven Morrison, Douglas E. Weitzel, Enrique Calderon Oliveras, Daniel Buck
-
Patent number: 10561808Abstract: A dose counter for an inhaler includes a counter display arranged to indicate dosage information, and a drive system arranged to move the counter display incrementally in a first direction from a first station to a second station in response to actuation input. A regulator is provided which is arranged to act upon the counter display at the first station to regulate motion of the counter display at the first station to incremental movements.Type: GrantFiled: September 12, 2016Date of Patent: February 18, 2020Assignees: IVAX PHARMACEUTICALS IRELAND, NORTON (WATERFORD) LIMITED, TEVA PHARMACEUTICALS IRELANDInventors: Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg
-
Publication number: 20200009335Abstract: An inhaler includes a mouthpiece cover, a pressure sensor, a first indicator and a second indicator. The first indicator may be configured to indicate based on a state of the cover, and the second indicator may be configured to indicate based on an output of the pressure sensor. For example, when the mouthpiece cover opens, the first indicator may illuminate and a dose of medication may be transferred from a reservoir to a dosing cup. The second indicator may illuminate if an amount of inhaled medication reaches a predetermined threshold for successful inhalation.Type: ApplicationFiled: September 16, 2019Publication date: January 9, 2020Applicant: Norton (Waterford) LimitedInventors: Enrique Calderon Oliveras, Daniel Buck, Frederic Scott Fleming, Douglas E. Weitzel
-
Patent number: 10463816Abstract: An inhaler includes a mouthpiece cover, a pressure sensor, a first indicator and a second indicator. The first indicator may be configured to indicate based on a state of the cover, and the second indicator may be configured to indicate based on an output of the pressure sensor. For example, when the mouthpiece cover opens, the first indicator may illuminate and a dose of medication may be transferred from a reservoir to a dosing cup. The second indicator may illuminate if an amount of inhaled medication reaches a predetermined threshold for successful inhalation.Type: GrantFiled: August 28, 2015Date of Patent: November 5, 2019Assignee: Norton (Waterford) LimitedInventors: Enrique Calderon Oliveras, Daniel Buck, Frederic Scott Fleming, Douglas E. Weitzel
-
Publication number: 20190262602Abstract: A breath actuated metered dose inhaler may comprise a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may comprise a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.Type: ApplicationFiled: January 25, 2019Publication date: August 29, 2019Applicant: Norton (Waterford) LimitedInventors: Declan Walsh, Paul Prendergast, Daniel Buck, Trevor Kent, Niall Thompson
-
Patent number: 10391267Abstract: A method of manufacturing a series of incremental dose counters for inhalers, which includes manufacturing the dose counters with nominal canister fire and dose count positions of a dose counter actuator relative to a dose counter chassis or inhaler main body, and which includes building the dose counters with an average dose count position in the series being, in canister fire process, at or after an average canister fire position in the series.Type: GrantFiled: May 15, 2015Date of Patent: August 27, 2019Assignees: IVAX PHARMACEUTICALS IRELAND, TEVA PHARMACEUTICALS IRELAND, NORTON (WATERFORD) LIMITEDInventors: Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg
-
Publication number: 20190247337Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.Type: ApplicationFiled: January 9, 2019Publication date: August 15, 2019Inventors: Philip J. BIRBARA, Daniel BUCKS
-
Publication number: 20190167926Abstract: A nasal inhaler for the inhalation of inhalable substances comprise: a canister having an interior reservoir containing pressurised inhalable substances including fluid; a metering valve including a metering chamber and a valve stem defining a communication path between the metering chamber and the interior reservoir, the communication path including an opening configured to permit flow between a transfer space inside the valve stem and the interior reservoir, the interior reservoir being arranged for orientation above the metering chamber whereby gas located within the metering chamber is replaced with liquid from the interior reservoir.Type: ApplicationFiled: February 7, 2019Publication date: June 6, 2019Applicant: Norton (Waterford) LimitedInventors: Daniel Buck, Paul Prendergast, Declan Walsh